It has been shown that USP9X positively regulates the protein stability of induced myeloid leukemia cell differentiation protein (MCL1) [74,78], a BCR-ABL dependent target implicated in drug resistance and cell survival of hematopoietic diseases [78]. The gene discussed is USP9X; the disease is hematologic disorder.